Bank of New York Mellon’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-6,655
| Closed | -$29K | – | 4575 |
|
2022
Q3 | $29K | Hold |
6,655
| – | – | ﹤0.01% | 4403 |
|
2022
Q2 | $35K | Sell |
6,655
-24,705
| -79% | -$130K | ﹤0.01% | 4422 |
|
2022
Q1 | $376K | Hold |
31,360
| – | – | ﹤0.01% | 3878 |
|
2021
Q4 | $613K | Buy |
31,360
+782
| +3% | +$15.3K | ﹤0.01% | 3663 |
|
2021
Q3 | $796K | Buy |
30,578
+6,501
| +27% | +$169K | ﹤0.01% | 3532 |
|
2021
Q2 | $530K | Buy |
24,077
+21,168
| +728% | +$466K | ﹤0.01% | 3742 |
|
2021
Q1 | $68K | Buy |
+2,909
| New | +$68K | ﹤0.01% | 4211 |
|
2019
Q4 | – | Sell |
-735
| Closed | -$16K | – | 4241 |
|
2019
Q3 | $16K | Hold |
735
| – | – | ﹤0.01% | 4185 |
|
2019
Q2 | $17K | Sell |
735
-2,351
| -76% | -$54.4K | ﹤0.01% | 4184 |
|
2019
Q1 | $119K | Sell |
3,086
-348
| -10% | -$13.4K | ﹤0.01% | 3966 |
|
2018
Q4 | $158K | Buy |
3,434
+1,433
| +72% | +$65.9K | ﹤0.01% | 3892 |
|
2018
Q3 | $274K | Buy |
2,001
+55
| +3% | +$7.53K | ﹤0.01% | 3846 |
|
2018
Q2 | $917K | Buy |
+1,946
| New | +$917K | ﹤0.01% | 3286 |
|